Form 4 for TMO Thermo Fisher Scientific
Accepted 2024-07-29 00:00:00 ET · period of report 2024-07-26 · accession 0001127602-24-021121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-07-29 | 2024-07-26 | TMO | Holmes Joseph R. | VP, CAO | M - OptEx | $230.07 | +860 | 2,199 | +64% | +$197.9K |
| DM | 2024-07-29 | 2024-07-26 | TMO | Holmes Joseph R. | VP, CAO | S - Sale+OE | $611.03 | -860 | 1,814 | -32% | -$525.5K |
| DM | 2024-07-29 | 2024-07-26 | TMO | Holmes Joseph R. | VP, CAO | M - OptEx | $0.00 | -860 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-26 | M | A | 475 | $210.68 | 2,288.52 | D | — | — | (F1) Includes 27.6245 shares acquired under the Issuer's employees' stock purchase plan on May 15, 2024. |
| 2 | Common | Common Stock | 2024-07-26 | S | D | 475 | $610.67 | 1,813.52 | D | — | — | |
| 3 | Common | Common Stock | 2024-07-26 | M | A | 385 | $253.99 | 2,198.52 | D | — | — | |
| 4 | Common | Common Stock | 2024-07-26 | S | D | 385 | $611.47 | 1,813.52 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-07-26 | M | D | 385 | $0.00 | 385 | D | $253.99 · — to 2026-02-26 | 385 Common Stock | (F2) The option vested in four equal installments on February 26, 2020, 2021, 2022, and 2023. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-07-26 | M | D | 475 | $0.00 | 0 | D | $210.68 · — to 2025-02-27 | 475 Common Stock | (F3) The option vested in four equal installments on February 27, 2019, 2020, 2021, and 2022. |